First Manhattan
OCRX

First Manhattan’s Ocera Therapeutics, Inc. OCRX Stock Holding History

First Manhattan’s Portfolio OCRX Stock Details OCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,000
Closed -$3K – 1514
2015
Q2 		$3K Buy
+1,000
New +$3.83K ﹤0.01% 1352

Other funds holding OCRX

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

First Manhattan's OCRX Position: Q3 2015 in Review

First Manhattan sold out of Ocera Therapeutics, Inc. (OCRX) in Q3 2015, closing a stake of 1,000 shares — an estimated $3K sold.

First Manhattan first reported a position in OCRX in Q2 2015 and held it in 1 quarter. The position peaked at $3K in Q2 2015. 27 funds tracked by Wall St. Rank hold OCRX as of Q3 2015.

  • First Manhattan reported no remaining Ocera Therapeutics, Inc. position as of Q3 2015 after selling out during the quarter.
  • First Manhattan sold 1,000 Ocera Therapeutics, Inc. shares in Q3 2015, an estimated $3K.
  • First Manhattan first reported a position in Ocera Therapeutics, Inc. in Q2 2015 and held it in 1 quarter.
  • First Manhattan's Ocera Therapeutics, Inc. position peaked at $3K in Q2 2015.
  • 27 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q3 2015.

Based on First Manhattan's 13F filing for Q3 2015, filed 26 Oct 2015.